These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sugammadex: when should we be giving it? Bailey CR Anaesthesia; 2017 Oct; 72(10):1170-1175. PubMed ID: 28695993 [No Abstract] [Full Text] [Related]
24. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis. Vieira Carlos R; Luis Abramides Torres M; de Boer HD Paediatr Anaesth; 2018 Apr; 28(4):342-346. PubMed ID: 29399936 [TBL] [Abstract][Full Text] [Related]
25. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Jones RK; Caldwell JE; Brull SJ; Soto RG Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293 [TBL] [Abstract][Full Text] [Related]
26. Case report: Neuromuscular block induced by rocuronium following sugammadex administration. Askin T; Unver S; Oguz D; Kutay K J Clin Anesth; 2017 Feb; 37():166-167. PubMed ID: 28235515 [TBL] [Abstract][Full Text] [Related]
27. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O; White PF; Tufanogullari B; Klein K Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [TBL] [Abstract][Full Text] [Related]
29. Anaphylaxis to rocuronium. Donnelly T Br J Anaesth; 2000 May; 84(5):696. PubMed ID: 10844854 [No Abstract] [Full Text] [Related]
30. [Sugammadex use experience in pediatric oncology]. Matinyan NV; Saltanov AI; Mareeva AA Anesteziol Reanimatol; 2013; (1):34-7. PubMed ID: 23808251 [TBL] [Abstract][Full Text] [Related]
31. Coagulation Effect of Sugammadex as Determined by Thromboelastography in a Randomized Controlled Study of Surgical Patients. Chang HW; Lee IO; Kang H; Won YJ; Lim YS Int J Med Sci; 2021; 18(6):1318-1324. PubMed ID: 33628086 [No Abstract] [Full Text] [Related]
32. Use of Sugammadex in Patients With Obesity: A Pooled Analysis. Monk TG; Rietbergen H; Woo T; Fennema H Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716 [TBL] [Abstract][Full Text] [Related]
33. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal. Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159 [TBL] [Abstract][Full Text] [Related]
34. A case of anaphylaxis apparently induced by sugammadex and rocuronium in successive surgeries. Yamada Y; Yamamoto T; Tanabe K; Fukuoka N; Takenaka M; Iida H J Clin Anesth; 2016 Aug; 32():30-2. PubMed ID: 27290941 [TBL] [Abstract][Full Text] [Related]
35. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. Dahl V; Pendeville PE; Hollmann MW; Heier T; Abels EA; Blobner M Eur J Anaesthesiol; 2009 Oct; 26(10):874-84. PubMed ID: 19455040 [TBL] [Abstract][Full Text] [Related]
37. Incidence of Anaphylaxis Associated With Sugammadex. Miyazaki Y; Sunaga H; Kida K; Hobo S; Inoue N; Muto M; Uezono S Anesth Analg; 2018 May; 126(5):1505-1508. PubMed ID: 29064876 [TBL] [Abstract][Full Text] [Related]
38. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888 [TBL] [Abstract][Full Text] [Related]
39. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265 [TBL] [Abstract][Full Text] [Related]
40. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]